1 / 10

Gutzmer , R; Wollenberg , A; Ugurel , S; Homey , B; Ganser, A; Kapp, A

Gutzmer , R; Wollenberg , A; Ugurel , S; Homey , B; Ganser, A; Kapp, A Cutaneous Side Effects of New Antitumor Drugs: Clinical Features and Management Dtsch Arztebl Int 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133.

unity-francis
Download Presentation

Gutzmer , R; Wollenberg , A; Ugurel , S; Homey , B; Ganser, A; Kapp, A

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  2. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  3. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  4. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  5. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  6. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  7. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  8. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  9. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

  10. Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous Side Effectsof New Antitumor Drugs: Clinical Features and Management DtschArzteblInt 2012; 109(8): 133-40; DOI: 10.3238/arztebl.2012.0133

More Related